Stewart Christopher P. 4
4 · Bionano Genomics, Inc. · Filed May 16, 2022
Insider Transaction Report
Form 4
Stewart Christopher P.
Chief Financial Officer
Transactions
- Exercise/Conversion
Common Stock
2022-05-13$0.56/sh+60,000$33,600→ 121,579 total - Exercise/Conversion
Stock Option (Right to Buy)
2022-05-13−60,000→ 117,500 totalExercise: $0.56Exp: 2030-09-01→ Common Stock (60,000 underlying)
Footnotes (2)
- [F1]Includes 3,139 shares acquired under the Issuer's 2018 Employee Stock Purchase Plan (the "ESPP") on June 10, 2021 and 2,940 shares acquired under the ESPP on December 10, 2021.
- [F2]The shares vest in full on December 31, 2020, subject to Reporting Person's continuous service through December 31, 2020, subject to acceleration of vesting provided in the Employment Agreement, dated as of September 1, 2020, by and between the Issuer and the Reporting Person.